Zhuomiaoyu Chen
Beijing, 100044, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Mendelian Randomization and Single-Cell Transcriptomic Analyses Implicate PPP1R1B as a Risk Factor of Intrahepatic Cholangiocarcinoma.
Journal: Genes
Published: May 29, 2026
Multi-omics-driven discovery of invasive patterns and treatment strategies in CA19-9 positive intrahepatic cholangiocarcinoma.
Journal: Journal of translational medicine
Published: July 21, 2024
Hepatocyte-specific Smad4 deficiency inhibits hepatocarcinogenesis by promoting CXCL10/CXCR3-dependent CD8+- T cell-mediated anti-tumor immunity.
Journal: Theranostics
Published: April 12, 2024
Integrative analysis reveals different feature of intrahepatic cholangiocarcinoma subtypes.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 16, 2023
WWP1 upregulation predicts poor prognosis and promotes tumor progression by regulating ubiquitination of NDFIP1 in intrahepatic cholangiocarcinoma.
Journal: Cell death discovery
Published: November 18, 2021
Endogenous tRNA-derived small RNA (tRF3-Thr-AGT) inhibits ZBP1/NLRP3 pathway-mediated cell pyroptosis to attenuate acute pancreatitis (AP).
Journal: Journal of cellular and molecular medicine
Published: June 11, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026